Charles River Laboratories | CRL - Net Income



Charles River Laboratories reported $52.33M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Agilent USD 336M 121M Jul/2025
Align Technology USD 124.61M 31.38M Jun/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Bruker USD 7.6M 9.8M Jun/2025
Cardinal Health USD 239M 267M Jun/2025
Charles River Laboratories USD 52.33M 26.86M Jun/2025
Cigna USD 1.53B 209M Jun/2025
CVS Health USD 1.02B 758M Jun/2025
Danaher USD 555M 399M Jun/2025
Dentsply International USD -45000000 65M Jun/2025
Elevance Health USD 1.74B 440M Jun/2025
Galapagos EUR -105748000 47.66M Jun/2025
Hologic USD 194.9M 212.3M Jun/2025
Humana USD 545M 699M Jun/2025
Illumina USD 235M 104M Jun/2025
Incyte USD 405M 246.8M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
Laboratory Of America USD 237.9M 25.1M Jun/2025
Lonza CHF 307M 22M Dec/2024
McKesson USD 784M 476M Jun/2025
Merck EUR 652M 83M Jun/2025
Mettler Toledo International USD 202.35M 38.76M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Quest Diagnostics USD 282M 62M Jun/2025
Revvity USD 53.95M 11.71M Jun/2025
Thermo Fisher Scientific USD 1.62B 110M Jun/2025
United Therapeutics USD 309.5M 12.7M Jun/2025
UnitedHealth USD 3.41B 2.89B Jun/2025
Waters USD 147.11M 25.73M Jun/2025
West Pharmaceutical Services USD 131.8M 42M Jun/2025